Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition

The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China HANGZHOU, China, Nov. 4, 2026 /PRNewswire/ — Zuellig Pharma, a leading healthcare solutions company in Asia, announced the. ..

Read full story on Pr Newswire Apac